Hsbc Holdings PLC Has $88.23 Million Stock Position in Kenvue Inc. $KVUE

Hsbc Holdings PLC boosted its holdings in shares of Kenvue Inc. (NYSE:KVUE) by 31.8% in the 4th quarter, Holdings Channel reports. The firm owned 5,106,368 shares of the company’s stock after buying an additional 1,230,957 shares during the period. Hsbc Holdings PLC’s holdings in Kenvue were worth $88,231,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently modified their holdings of the business. Physician Wealth Advisors Inc. raised its holdings in shares of Kenvue by 67.5% during the 4th quarter. Physician Wealth Advisors Inc. now owns 1,533 shares of the company’s stock worth $26,000 after buying an additional 618 shares in the last quarter. Mill Creek Capital Advisors LLC raised its stake in Kenvue by 0.6% during the fourth quarter. Mill Creek Capital Advisors LLC now owns 124,213 shares of the company’s stock worth $2,143,000 after acquiring an additional 701 shares in the last quarter. B & T Capital Management DBA Alpha Capital Management lifted its holdings in shares of Kenvue by 0.3% in the fourth quarter. B & T Capital Management DBA Alpha Capital Management now owns 234,664 shares of the company’s stock worth $4,048,000 after acquiring an additional 712 shares during the last quarter. Philip James Wealth Mangement LLC boosted its stake in shares of Kenvue by 5.5% in the 4th quarter. Philip James Wealth Mangement LLC now owns 13,888 shares of the company’s stock valued at $240,000 after purchasing an additional 726 shares in the last quarter. Finally, IFG Advisory LLC grew its holdings in shares of Kenvue by 5.4% during the 4th quarter. IFG Advisory LLC now owns 15,051 shares of the company’s stock valued at $260,000 after purchasing an additional 766 shares during the last quarter. Institutional investors own 97.64% of the company’s stock.

Insider Transactions at Kenvue

In other Kenvue news, General Counsel Matthew Orlando sold 38,491 shares of the firm’s stock in a transaction on Friday, May 8th. The shares were sold at an average price of $17.66, for a total value of $679,751.06. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 1.59% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

A number of brokerages have weighed in on KVUE. Weiss Ratings upgraded shares of Kenvue from a “hold (c-)” rating to a “hold (c)” rating in a research report on Monday, June 15th. Barclays cut their price objective on Kenvue from $19.00 to $18.00 and set an “equal weight” rating on the stock in a report on Tuesday, April 14th. Citigroup lowered their target price on Kenvue from $20.00 to $19.00 and set a “neutral” rating for the company in a report on Wednesday, April 15th. Argus upgraded Kenvue to a “hold” rating in a research report on Friday, March 6th. Finally, Zacks Research raised Kenvue from a “hold” rating to a “strong-buy” rating in a research note on Friday, May 8th. One analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and twelve have issued a Hold rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $19.33.

Kenvue Stock Up 0.3%

Shares of Kenvue stock opened at $18.17 on Monday. Kenvue Inc. has a one year low of $14.02 and a one year high of $22.87. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.98 and a quick ratio of 0.70. The stock’s 50-day moving average is $17.54 and its 200 day moving average is $17.57. The firm has a market cap of $34.88 billion, a price-to-earnings ratio of 21.37, a PEG ratio of 1.37 and a beta of 0.54.

Kenvue (NYSE:KVUE) last issued its earnings results on Thursday, May 7th. The company reported $0.32 earnings per share for the quarter, topping analysts’ consensus estimates of $0.27 by $0.05. Kenvue had a return on equity of 20.81% and a net margin of 10.61%.The business had revenue of $3.91 billion during the quarter, compared to the consensus estimate of $3.84 billion. During the same period in the previous year, the company posted $0.24 earnings per share. The firm’s revenue for the quarter was up 4.5% on a year-over-year basis. Equities research analysts anticipate that Kenvue Inc. will post 1.16 EPS for the current year.

Kenvue Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, May 27th. Stockholders of record on Wednesday, May 13th were paid a $0.2075 dividend. The ex-dividend date was Wednesday, May 13th. This represents a $0.83 annualized dividend and a dividend yield of 4.6%. Kenvue’s payout ratio is currently 97.65%.

Kenvue Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.